publicações selecionadas
- A Review of Real-World Use of Ceftazidime-avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
- Re: -Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes? by Nutman et al.
- In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
- Testes Conceituais Relativos Ao Conhecimento Terapêutico em Pseudomonas Aeruginosa Produtoras de São Paulo Metalo-Beta-Lactamase (Spm-1)
- In vitro synergy of ticarcillin/clavulanate in combination with aztreonam and ceftolozane/tazobactam against SPM-1-producing Pseudomonas aeruginosa strains
- Simulação de Monte Carlo para definição do tratamento ideal para pacientes hospitalizados por Infecção de Trato Urinário por Escherichia coli
- Broad-spectrum antimicrobial consumption trends and correlation with bacterial infections and antimicrobial resistance over 5 years
- Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration
- In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa
- Evaluation of high-concentration EDTA-modified carbapenemase inactivation method (eCIM) for SPM-producing Pseudomonas aeruginosa
- SIMULAÇÃO DE MONTE CARLO PARA ESTIMATIVA DE TERAPIA ÓTIMA EM PACIENTES COM INFECÇÃO DO TRATO URINÁRIO CAUSADA POR ESCHERICHIA COLI